US20070225757A1 - Closure device - Google Patents

Abstract

A medical closure device (20) is provided, which comprises a tubular member (21) provided with a first set of struts (22) that extend between a first end portion (24) and a central portion (25) and a second set of struts (23) that extend between said central portion (25) and a second end portion (26), and each strut (22, 23) being provided with a section (27, 28) that can act as a hinge, such that said closure device (20) being movable between a first elongated tubular configuration and a second configuration in which the first and second end portions (24, 26) have been moved towards each other such that the first and second struts (22, 23) have moved radially away from a longitudinal central axis of the closure device. The closure device (20) comprises further a separate locking member (30) with such a shape that the closure device can be locked in the second configuration.

Description

• The present invention relates generally to a medical device for closing an opening or defect in an organ within a living body, e.g. a septal defect in a heart or a percutaneous puncture in a vessel wall, and in particular to an expandable and repositionable closure device, which can be remotely maneuvered from an initial positioning configuration to a final configuration in which the opening or defect is closed.
BACKGROUND OF THE INVENTION
• The closing of an opening in an organ of a patient is a medical procedure that frequently has to be practised by doctors or other trained medical personnel. The opening may be a hole created by the doctor for a specific and usually temporary purpose, or the opening can be a congenital or acquired defect. An example of the former would be a puncture hole created in a patient's femoral artery to obtain access to the coronary system, while an example of the latter is a septal defect in a patient's heart. For descriptive and illustrative purposes the present invention will be described with reference to such a septal defect, although such techniques can be applied to other fields of application, such as walls in arteries or other blood vessels.
• As is well-known, the human heart is divided into four chambers: the left atrium, the right atrium, the left ventricle, and the right ventricle. The atria are separated from each other by the interatrial septum, and the ventricles are separated by the interventricular septum.
• Either congenitally or by acquisition, abnormal openings or holes can form between the chambers of the heart, causing shunting of blood through the opening or hole. For example, with an atrial septal defect, blood is shunted from the left atrium to the right atrium, which produces an over-load of the right side of the heart. In addition to left-to-right shunts such as occur in patent ductus arteriosus from the aorta to the pulmonary artery, the left side of the heart has to work harder because some of the blood will recirculate through the lungs instead of going to the rest of the body. The ill effects of such lesions usually cause added strain on the heart with ultimate failure if not corrected.
• One way to cure a septal defect in the septum of a heart is to position and anchor a specially designed closure device at the septum such that both sides of the septal defect are spanned by the closure device to thereby close the defect. Examples of such septal defect closure devices are known from the U.S. Pat. Nos. 5,853,422; 6,024,756; 6,117,159 and 6,312,446 to Huebsch et al., which disclose a closure device comprising a cylindrical shaft of metal or polymeric material with concentric parallel cuts through the wall of the device to thereby create flattened support struts. The centers of the support struts are intended to move radially away from the longitudinal axis of the device in a hinge like fashion in response to movements of the proximal and distal ends of the device towards the centre thereof. A special feature of the known septal defect closure device is that it is of a unitary construction.
• A similar septal defect closure device is also disclosed in the international application WO 2005/006990 A2.
SUMMARY OF THE INVENTION
• One general object of the present invention is to improve a closure device of the aforementioned type in such a way that a more reliable and versatile device is obtained, which more easily can be adapted to the special characteristics of individual patients as well as individual openings, e.g. septal defects or puncture holes.
• According to the present invention, a septal defect closure device comprises an elongated tubular member in which a first set of longitudinal slits or cuts has been made on a first side of a shorter uncut central portion and a second set of longitudinal slits or cuts has been made on the opposite side of the central portion. On each side of the central portion, the slits extend towards the ends of the tubular member to terminate a short distance before the respective end, such that uncut proximal and distal end portions are formed. The tubular member, which is made from a flexible and preferably resorbable material, has thereby been provided with proximal and distal sets of struts or ribs. The distal ends of the distal struts are flexibly connected to the distal end portion of the tubular member, while the proximal ends of the distal struts are flexibly connected to the central portion. Similarly, the proximal ends of the proximal struts are flexibly connected to the proximal end portion of the tubular member, while the distal ends of the proximal struts are flexibly connected to the central portion. The struts are further each provided with a weakened section, which can act as a hinge, such that each strut in effect is divided into two articulated arms.
• When the septal defect closure device during use is compressed such that the distal and proximal end portions are forced towards each other, the weakened sections of the struts move radially out from the longitudinal central axis of the closure device, and the respective arms of the struts assume an essentially perpendicular angle to the central axis of the closure device. According to the invention, the septal defect closure device comprises further a central cylindrical locking member, which is separate from the tubular member and which over its length comprises several portions with different diameters. In use, the cylindrical locking member is inserted into the tubular member such that the distal end portion of the tubular member abuts a distal end rim of the locking member, and the proximal end portion of the tubular member is then pushed over a proximal end rim of the locking member. In the compressed state, the central, proximal and distal portions of the tubular member fit snugly over respective portions of the central locking member, and the closure device is held in the compressed state by the enlarged distal and proximal rim portions of the locking member, which prevents the closure device from resuming its original tubular shape.
• In an alternative embodiment of the invention, the septal defect closure device comprises two separate slit tubular members, which can slide on a common, separate locking member. In practice, these two separate slit tubular members would thereby correspond to a closure device as already described above, which at its central portion is cut into two separate halves. A three-piece closure device will give a doctor enhanced possibilities to adapt a closure device to a patient's specific requirements.
• By providing a locking member which is separate from the slit elongated tubular members, a doctor can easily adapt a septal defect closure device to different septa having different thicknesses by simply selecting a locking member of a suitable length. With a separate locking member a closure device can be easier and cheaper to manufacture. A separate locking member can also be made from a different material than the rest of the closure device, to thereby, for example, match the resorption time of a locking member to the resorption time of a tubular member despite their different dimensions and shapes. In other words, a separate locking member can be regarded as a prerequisite for a more reliable and versatile closure device, which also is easier and cheaper to manufacture and which also allows separate modifications of the tubular member without changing the design of the locking member.
BRIEF DESCRIPTION OF THE DRAWINGS
• FIG. 1 is a schematic illustration of a human heart having an atrial as well as a ventricular septal defect.
• FIG. 2 is a schematic illustration of a human heart having a septal defect, which is to be closed by means of a medical procedure that, in a first step, involves the positioning of a septal defect closure device according to the present invention.
• FIG. 3 illustrates an intermediate step in the medical procedure, in which a distal portion of the closure device ofFIG. 2 is expanded in order to locate the septal defect from the distal side of the septal defect.
• FIG. 4 illustrates another intermediate step in the medical procedure, in which a proximal portion of the closure device ofFIG. 2 is expanded in order to locate the septal defect from the proximal side of the septal defect.
• FIG. 5 illustrates the completion of the medical procedure, wherein the closure device ofFIG. 2 has been secured in the septum surrounding the septal defect.
• FIG. 6 shows a septal defect closure device according to the invention in a positioning configuration before the longitudinal compression of the closure device.
• FIG. 7 shows the closure device ofFIG. 6 in an intermediate semi-compressed state.
• FIG. 8 shows a locking member which constitutes a separate part of a septal defect closure device.
• FIG. 9 shows the closure device ofFIG. 6 locked in a final compressed state.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
• A schematic cross-sectional view of ahuman heart1 is shown inFIG. 1. Theheart1, with itsleft ventricle2,left atrium3,right ventricle4 andright atrium5, suffers from an atrialseptal defect6 as well as a ventricularseptal defect7. Below a medical procedure will be discussed in which an atrial septal defect is closed. It should, however, be clear that a septal defect closure device according to the present invention equally well could be employed to close a ventricular septal defect like ventricularseptal defect7 ofFIG. 1. It should further be noticed that theseptal defects6,7 can be accessed from different vessels, e.g. from the superior or inferior vena cava, or from the aorta. This implies, in turn, that throughout the present description terms like “distal” and “proximal” should always be seen from the end of a delivering catheter, through which a septal defect closure device is delivered (and not from any particular chamber or vessel of a heart).
• In conjunction with FIGS.2 to5, a medical procedure will be briefly described, in which a septal defect closure device according to one embodiment of the present invention is employed to close a septal defect in the septum of a heart; and thereafter different positions and parts of the closure device itself will be described in detail in conjunction with FIGS.6 to9.
• FIG. 2 illustrates a septaldefect closure device10 according to the present invention, which by means of a deliveringcatheter11 has been introduced into an atrialseptal defect12 in theatrial septum13 of aheart14. Theclosure device10 is of the same general construction that has been generally described above, and comprises an elongated tubular member in which distal and proximal sets of struts have been provided. The distal struts extend from a central portion of theclosure device10 to a distal end portion thereof, and the proximal struts extend from a proximal end portion of theclosure device10 to the central portion. As already discussed, each strut is provided with a thinner and thereby weaker section that can act as a hinge, and each strut is thereby effectively divided into two hinge-connected arms. InFIG. 2, theclosure device10 is shown in an initial positioning configuration, in which the arms of each strut are substantially aligned with each other. In this uncompressed positioning configuration, theclosure device10 has therefore a generally elongated tubular shape, which facilitates the introduction of theclosure device10 into the artery and heart of a patient.
• To ascertain correct positioning of theclosure device10 with respect to theseptal defect12, the distal set of struts can be moved radially outwards from the central axis of theclosure device10, such that a partly expanded configuration is obtained. The radial movements of the distal struts are effectuated by partially compressing theclosure device10 through the maneuvering of a mechanical actuator (not shown in the figures). In this semi-expanded locating configuration, theclosure device10 is retracted until the distal struts abut the distal side of theatrial septum13 surrounding theseptal defect12. Theseptal defect12 can thereby be located by a doctor, who in this phase of the medical procedure will feel a marked increase in resistance against further retraction. This intermediate step of the medical procedure is depicted inFIG. 3.
• As an alternative or complement, the proximal set of struts can be moved radially outwards from the central axis of theclosure device10, such that another partly expanded configuration is obtained. As before, the radial movements of the proximal struts are accomplished by partially compressing theclosure device10 through the maneuvering of the mechanical actuator mentioned above. In this second semi-expanded locating configuration, theclosure device10 is advanced out of thecatheter11 until the proximal struts abut the proximal side of theatrial septum13 surrounding theseptal defect12. Theseptal defect12 can thereby be located by a doctor who in this phase of the medical procedure will feel a marked increase in resistance against further advancement. This intermediate step of the medical procedure is depicted inFIG. 4. It may be mentioned that theclosure device10 can be reversibly moved between the elongated tubular positioning configuration ofFIG. 2 and either of the intermediate configurations shown inFIG. 3 andFIG. 4, respectively.
• When theatrial septum13 and thereby theseptal defect12 have been correctly located, either by the step shown inFIG. 3 or by the step ofFIG. 4, or by both steps, theclosure device10 is fully expanded such that the proximal struts as well as the distal struts are forced radially outwards by maneuvering of the mechanical actuator mentioned above. In this closing configuration, theclosure device10 spans both the distal side and the proximal side of theseptal defect12, and is then held in this position. As can be seen inFIG. 5, theclosure device10 sandwiches theatrial septum13 to thereby close theseptal defect12 therein. It can be mentioned that the term “close” or similar terms used herein in conjunction with the description of the closing of a septal defect should not be taken too literally. Such terms are meant to encompass all stages from actually sealing or closing off a septal defect to merely restricting the flow of blood therethrough, the important thing being that the closure device permits and facilitates healing of the septal (or other type of) defect over time. To improve the sealing capability of a closure device of the present type, it is conceivable that the distal and/or proximal struts at least partly are covered by a thin membrane, which preferably is made from a resorbable material. This feature may in particular be advantageous when the closure device is used to seal a puncture hole in a vessel wall.
• An embodiment of a septaldefect closure device20 according to the present invention is illustrated inFIG. 6.FIG. 6 shows theclosure device20 in a first or positioning configuration in which theclosure device20 has the general shape of anelongated tubular member21, through which a number of longitudinal, parallel cuts or slits have been made to thereby form a first or distal set ofstruts22 and a second or proximal set ofstruts23. The first strut set22 extends between afirst end portion24 of thetubular member21 and acentral portion25 thereof, while the second strut set23 extends between thecentral portion25 and asecond end portion26 of thetubular member21. The first andsecond end portions24,26 as well as thecentral portion25 are uncut and are shorter than the slit portions of thetubular member21. Somewhere along the length of the first set ofstruts22, thetubular member21 has been provided with a circumferential weakenedsection27 in that material has been removed from this ring-shaped section of thetubular member21. The weakenedthinner section27 of eachstrut22 will thereby act as a hinge orarticulation27, which effectively divides eachstrut22 into two articulated arms: a first ordistal arm22aand a second orproximal arm22b.Similarly, the struts in second set ofstruts23 are each provided withhinge section28, which in effect divides eachstrut23 into two articulated arms: a first ordistal arm23aand a second orproximal arm23b.
• Here it should be emphasized that the term “tubular” is merely intended to indicate the general shape of an elongated, cylindrical member, which comprises a number of struts, the ends of which are connected to shorter ring-shaped members, and which in a first positioning configuration assumes a tubular shape. In other words, a tubular member, liketubular member21, does not actually have to be cut or slit in order to create distal and proximal struts. On the contrary, a tubular member, having struts with weakened hinge-sections as well as ring-shaped central, distal and proximal end portions, can advantageously be directly produced in this form, e.g. by injection molding. It can therefore be appreciated that a separate locking member simplifies the manufacture of a closure device of the present type, because, for example, the injection mold can be given a much less elaborated shape.
• InFIG. 7, theclosure device20 ofFIG. 6 is depicted in a semi-expanded state in which the distal andproximal end portions24,26 of theclosure device20 have been moved towards thecentral portion25. Thehinge sections27,28 of the first andsecond struts22,23 have thereby been forced to move outwards from the central axis of theclosure device20, and the articulatedarms22a,22band23a,23bhave assumed an angled relation to the central axis of theclosure device20. Here it should be recognized that the configuration shown inFIG. 7 partly is for illustrative purposes; in practice either of the twoend portions24,26 could be moved towards thecentral portion25, to assume the locating configurations shown inFIG. 3 andFIG. 4, respectively. The semi-expanded configuration ofFIG. 7 could, however, also be used to determine the proper position for theclosure device20, and can also be regarded as a configuration prior to a fully closed configuration described below in conjunction withFIG. 9.
• As can be seen inFIG. 7, theclosure device20 comprises further a lockingmember30, which is separately illustrated inFIG. 8. The lockingmember30, which according to the invention constitutes a separate part ofclosure device20, comprises ahollow body31, which along is length is provided with several portions with different outer diameters. More specifically, thebody31 of the lockingmember30 comprises adistal end rim32, adistal portion33, anintermediate portion34, aproximal portion35, and aproximal end rim36. The distance between thedistal end rim32 and theproximal end rim36 is considerably smaller than the length of thetubular member21. As the observant reader already may have appreciated, the respective outer diameters of the lockingmember30 are related to the respective diameters of thetubular member21 of theclosure device20. Thus, the diameter of the distal end rim32 is larger than the inner diameter of thedistal end portion24 of thetubular member20, while the inner diameter of thedistal end portion24 is larger than the other diameters of thebody31 of the lockingmember30, such that thedistal end portion24 of thetubular member21 can slide over the lockingmember30 until thedistal end portion24 abuts thedistal end rim32. The outer diameter of thedistal portion33 of the lockingmember30 is adapted to the inner diameter ofdistal end portion24 of thetubular member21, while the diameter of theintermediate portion34 is adapted to the diameter of thecentral portion25 of thetubular member21. The inner diameter of theproximal end portion26 of thetubular member21 is adapted to the outer diameter of theproximal portion35 of the lockingmember30, and is slightly less than the diameter of theproximal end rim36. During use, theproximal end portion26 of thetubular member21, which is made from a somewhat elastic material, must therefore be forced over theproximal end rim36 and can then slide on theproximal portion35. As can be seen inFIG. 8, the lockingmember30 comprises preferably arecess37, which provides the proximal end rim36 with a certain resilience which facilitates the sliding of theproximal end portion26 of theclosure device20 over the proximal end rim36 of the lockingmember30.
• InFIG. 9, theclosure device20 is shown in a closed and locked state, in which the distal andproximal end portions24,26 of thetubular member21 have been fully moved towards each other until thecentral portion25 is positioned over theintermediate portion34 of the lockingmember30 and theproximal end portion26 has been moved over the proximal end rim36 of the lockingmember30. Theclosure device20 is held in this compressed state due to the enlarged distal and proximal end rims32,36 of the lockingmember30, which have diameters larger than thedistal end portion24 and theproximal end portion26, respectively.
• InFIGS. 6, 7 and9, thecentral portion25 of thetubular member21 has been depicted with a longitudinal length approximately equal to the lengths of the distal andproximal end portions24,26. The length of a central portion of a tubular member can, however, be varied, e.g., be longer, and can in particular be adjusted to the thickness of a particular septum at which the corresponding closure device is to be placed.
• Another way to facilitate the adaptation of a septal defect closure device to septa having different thicknesses is to arrange the distal set of struts and the proximal set of struts as two separate members. Such an arrangement would effectively correspond to cutting a tubular member like thetubular member21 ofFIG. 6 into two separate tubular members. These two tubular members would then independently of each other be movable along the length of a common locking member similar to lockingmember30 ofFIG. 8; and it can further be appreciated that it would be easy to adapt a closure device of this type to a particular septum thickness by simply choosing a locking member whose different portions have suitable lengths. In other words, with a three-piece septal defect closure device, comprising a locking member and proximal and distal tubular members, the advantages of providing a separate locking member are even further exploited.
• The septal defect closure device has been shown with proximal and distal struts having equal lengths. It is, however, possible to provide a closure device having proximal struts with one length and distal struts with a different length. It may, for example, be desirable to arrange a closure device in such a way that the left part of the closure device, i.e. the part that is implanted into the left atrium of a heart, is smaller than the right part of the closure device, to thereby reduce the amount of artificial material introduced into the left atrium, which in turn may reduce the formation of thrombogenic material therein. In this context, it should be recognized that it is not mandatory that a heart is accessed via the venous system, as is shown in FIGS.2 to5, but the heart could be accessed via the arterial side. This implies that if a doctor wishes to place a smaller part of a closure device at the left side of a heart than at the right side of the heart, then this smaller part (i.e. the shorter struts) will constitute the distal set of struts if the heart is accessed via the venous system, whereas the smaller part will constitute the proximal set of struts if the heart is accessed through the arterial system. It can therefore be appreciated that it can be advantageous to provide a closure device in the form of two separate tubular members (and a separate locking member) as this would provide a doctor with the possibility to tailor a septal defect closure device to the specific medical situation at hand, without the necessity of producing an excessive large number of closure devices with different dimensions. For example, with only three different strut lengths for a distal tubular member, three different strut lengths for a proximal tubular member, and three different lengths for a locking member, it is possible to obtain twenty-seven (27) different combinations and thereby twenty-seven (27) different closure devices, each suited for a specific medical situation.
• It has already been mentioned that the length of the distal struts can differ from the length of the proximal struts; and it is also possible to have different lengths of the articulated arms within a strut set, such that, for example, the distal arms are longer than the proximal arms, or vice versa. The arms that actually contact a septum or a vessel wall can, for example, be shorter than the arms that do not contact the septum or the vessel wall, to thereby ensure a reliable closing of a septal defect in the septum or a puncture hole in the vessel wall.
• As already has been stated, a closure device comprising a central locking member that is separate from a tubular member can be regarded as a prerequisite for other advantageous effects. A two-piece closure device is generally easier and thereby cheaper to manufacture. If, for example, the closure device is produced by injection moulding, the moulds—i.e. one mould for the locking member and one mould for the tubular member—can be given comparatively less complicated shapes than if the closure device was to be moulded in a single mould.
• It is in particular anticipated that a locking member is made from a first material and that a tubular member is made from a second material, something which in practice may require that the locking member is separate from the tubular member. With different materials some specific advantages can be achieved. If, for example, the closure device is a resorbable closure device, then the resorption time of the material in the locking member can be different from the resorption time of the material in the tubular member, such that the locking force between the two members during the degradation of the closure device is reduced and ultimately lost in a controllable and predictable way. In this respect it may be advantageous if the material of the tubular member has a shorter resorption time than the material of the locking member. Further, whether or not the materials are resorbable materials, different requirements are put on the different pieces. For example, the material in the hinge portions of a tubular member must be flexible and have a high tenacity, whereas the locking member must have a rather high stiffness. Also in a resorbable closure device it can be necessary to have one material in a locking member and another material in a tubular member, because of the different dimensions involved. It can, for example, be necessary to have a material with a relatively long resorption time in the thin hinge portions of the tubular member in order to match the resorption time of the material in a thick-walled locking member.
• Examples of resorbable materials for the tubular member and the locking member may include, but are not limited to, those materials made from aliphatic polyesters, polyether esters, and polycarbonates. More specifically, synthetic resorbable polymers such as homopolymers and copolymers made from any of the monomers lactide, glycolide, epsilon-caprolactone, trimethylene carbonate, and paradioxanone are advantageous because of their long clinical use.
• The tubular member could preferably be made from a semi-crystalline material with a lower tensile modulus than the locking member. As previously stated, the device could, e.g. because of the hinge portions, have a more flexible material in the tubular member. Such material is preferably made from a block copolymer characterized by having a soft middle part characterized by having a glass transition temperature below room temperature and a semi-crystalline part at each end of the soft middle part. The semi-crystalline part could be polymerized from any of the monomers glycolide, lactide, or paradioxanone. Since polyparadioxanone is a relatively soft and pliable material compared to polyglycolide and polylactide, the tubular member can be made from pure polyparadioxanone itself.
• The locking member can be made from any of the above materials, but to secure the locking mechanism it is advantageous if the material is stiffer than the material used in the tubular member. The material should also preferably resorb at a somewhat slower pace than the tubular member. The locking member could also be made from amorphous or semi-crystalline material, and preferably from homopolymers or copolymers where the main monomer component is lactide, caprolactone, or paradioxanone.
• A particular advantage of the groups of synthetic resorbable polymers mentioned above is that various mechanical properties can be accomplished by simply changing the monomer composition in the homopolymer or copolymer. Further, in contrast to natural biopolymers, these materials can be molded and machined into complex structures, and by varying the monomer composition large time spans can be achieved for their resorption times.
• It may be appreciated that it can be advantageous to provide a radiopaque closure device which is visible in an X-ray machine. When the closure device is made from a synthetic resorbable polymer, a radiopaque closure device can conveniently be produced by mixing the polymer with a suitable radiopaque agent. A suitable radiopaque agent is barium sulfate, which can be blended into the polymer or copolymer in an amount between 5% and 50%, and more preferably in an amount of 15% to 30%, to obtain the opacity needed in order to locate the closure device during an X-ray observation. Radiopaque materials can be used in a tubular member of the closure device, but is preferably used in the locking member, which marks the centre of the device. The radiopaque agent, e.g. barium sulfate, can—instead of being mixed with the polymer—be introduced into preformed holes in the closure device, which are then sealed by a synthetic resorbable material. As an alternative, preformed holes can be plugged with a resorbable material containing a large amount of a radiopaque agent, e.g. barium sulfate.
• Other aspects, features, variations, and ways of using the present invention are described in the U.S. Patent Applications and filed under attorney docket numbers 030481/0250 (entitle “Closure Device”); 030481/0254 (entitled “Closure Device”); and 030481/0258 (“Closure Device and Insertion Assembly”) concurrently herewith. The entire contents of these related applications are incorporated herein by reference. Features in these different applications may be combined with each other
• Although the present invention has been described with reference to specific embodiments, also shown in the appended drawings, it will be apparent for those skilled in the art that many variations and modifications can be done within the scope of the invention as described in the specification and defined with reference to the claims below. It is possible to have different lengths of the articulated arms within a strut set, such that, for example, the distal arms are longer than the proximal arms, or vice versa. The weakened strut sections discussed above can be replaced with other designs that provide the desired hinge-like action. The hinge action could, for example, be accomplished by real hinges arranged along the struts.

Claims (17)

1. A medical closure device having a longitudinal central axis comprising:

a tubular member having a length and a first set of struts extending between a first end portion and a central portion and a second set of struts extending between said central portion and a second end portion,

each strut being provided with a hinge section that can act as a hinge, such that said closure device is movable between a first elongated tubular configuration and a second configuration in which the first and second end portions have been moved towards each other such that said hinge sections of the first and second sets of struts have moved radially away from said longitudinal central axis,

wherein the closure device further comprises a separate locking member, which has a first end rim with a diameter larger than a diameter of the first end portion and a second end rim whose diameter is adapted to the diameter of the second end portion, and a distance between the first and second end rims is smaller than the length of the tubular member, such that, when the locking member is positioned in the tubular member such that the first end rim abuts the first end portion, the second end portion can be moved over the second end rim such that the closure device is held in an expanded configuration in which the first and second sets of struts have moved radially away from said longitudinal central axis.

2. The medical closure device according toclaim 1, wherein the first set of struts is at least partly covered by a membrane.

3. The medical closure device according toclaim 1, wherein the second set of struts is at least partly covered by a membrane.

4. The medical closure device according toclaim 1, wherein said tubular member comprises two separate halves such that the respective halves can move independently of each other.

5. The medical closure device according toclaim 1, wherein the closure device at least partly is made from a synthetic resorbable polymer.

6. The medical closure device according toclaim 5, wherein said synthetic resorbable polymer is a polyester, a polyether ester, or a polycarbonate, or a mixture thereof.

7. The medical closure device according toclaim 6, wherein the closure device is made from homopolymers or copolymers made from any of the monomers lactide, glycolide, epsilon-caprolactone, trimethylene carbonate, and paradioxanone.

8. The medical closure device according toclaim 1, wherein said locking member is made from a first material and said tubular member is made from a second material.

9. The medical closure device according toclaim 8, wherein said first material is stiffer than said second material.

10. The medical closure device according toclaim 8, wherein said first material has a longer resorption time than said second material.

11. The medical closure device according toclaim 8, wherein said first material is made from homopolymers or copolymers where the main monomer component is lactide, caprolactone or paradioxanone.

12. The medical closure device according toclaim 8, wherein said second material is made from a block copolymer characterized by having a soft middle part characterized by having a glass transition temperature below room temperature and a semi-crystalline part at each end of the soft middle part.

13. The medical closure device according toclaim 12, wherein said semi-crystalline part is polymerized from any of the monomers glycolide, lactide and paradioxanone.

14. The medical closure device according toclaim 8, wherein said second material is polyparadioxanone.

15. The medical closure device according toclaim 1, wherein the closure device comprises a radiopaque agent.

16. The medical closure device according toclaim 1, wherein the closure device is adapted for closing a septal defect in a heart.

17. The medical closure device according toclaim 1, wherein the closure device is adapted for closing a puncture in a vessel wall.

Images